Aspire Biopharma Holdings, Inc. (ASBP)
8.95
+0.34
(+3.95%)
USD |
NASDAQ |
Sep 10, 15:53
Aspire Biopharma Holdings EPS Diluted (Quarterly) : -1.222 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.222 |
| March 31, 2026 | -20.57 |
| December 31, 2025 | -39.97 |
| September 30, 2025 | -44.83 |
| June 30, 2025 | -48.19 |
| March 31, 2025 | -0.4207 |
| December 31, 2024 | -33.29 |
| September 30, 2024 | -9.408 |
| June 30, 2024 | -4.212 |
| March 31, 2024 | -10.04 |
| December 31, 2023 | -20.14 |
| Date | Value |
|---|---|
| September 30, 2023 | -9.24 |
| June 30, 2023 | 68.47 |
| March 31, 2023 | 95.92 |
| December 31, 2022 | 74.47 |
| September 30, 2022 | 35.96 |
| June 30, 2022 | 4.032 |
| March 31, 2022 | -5.64 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.516 |
| June 30, 2021 | -0.096 |
| March 31, 2021 | -0.30 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Resonate Blends, Inc. | -0.0034 |
| Breakthrough Chemistry, Inc. | -0.1113 |
| Kaya Holdings, Inc. | -0.0581 |
| Cardiac Biotech Solutions, Inc. | -0.0008 |
| Endexx Corp. | -0.0022 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.268M |
| Revenue (Quarterly) | 0.0631M |
| Total Expenses (Quarterly) | 1.331M |
| Enterprise Value | -1.015M |
| Gross Profit Margin (Quarterly) | 19.49% |
| Profit Margin (Quarterly) | -2.01K% |
| Earnings Yield | -1.19K% |
| Normalized Earnings Yield | -1571.19 |